These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 2286699

  • 21. A predictive study of obsessive-compulsive disorder response to clomipramine.
    Alarcon RD, Libb JW, Spitler D.
    J Clin Psychopharmacol; 1993 Jun; 13(3):210-3. PubMed ID: 8354737
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR.
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clomipramine (Anafranil) and behaviour therapy in obsessive-compulsive and phobic disorders.
    Amin MM, Ban TA, Pecknold JC, Klingner A.
    J Int Med Res; 1977 Dec; 5 Suppl 5():33-7. PubMed ID: 340305
    [Abstract] [Full Text] [Related]

  • 33. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.
    Insel TR, Murphy DL, Cohen RM, Alterman I, Kilts C, Linnoila M.
    Arch Gen Psychiatry; 1983 Jun; 40(6):605-12. PubMed ID: 6342562
    [Abstract] [Full Text] [Related]

  • 34. Clomipramine in obsessive compulsive disorder.
    Lee S.
    J Clin Psychiatry; 1991 Apr; 52(4):183-5. PubMed ID: 2016256
    [No Abstract] [Full Text] [Related]

  • 35. Tricyclic response in obsessive compulsive disorder.
    Insel TR, Mueller EA, Gillin JC, Siever LJ, Murphy DL.
    Prog Neuropsychopharmacol Biol Psychiatry; 1985 Apr; 9(1):25-31. PubMed ID: 3991911
    [Abstract] [Full Text] [Related]

  • 36. Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action.
    Benkelfat C, Murphy DL, Zohar J, Hill JL, Grover G, Insel TR.
    Arch Gen Psychiatry; 1989 Jan; 46(1):23-8. PubMed ID: 2910220
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder.
    Austin LS, Lydiard RB, Ballenger JC, Cohen BM, Laraia MT, Zealberg JJ, Fossey MD, Ellinwood EH.
    Biol Psychiatry; 1991 Aug 01; 30(3):225-32. PubMed ID: 1832972
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.